29.12.2014 Views

ABSTRACTS - World Psychiatric Association

ABSTRACTS - World Psychiatric Association

ABSTRACTS - World Psychiatric Association

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

RS19.<br />

CURRENT CLINICAL PERSPECTIVES<br />

IN PSYCHOSOMATIC MEDICINE<br />

RS19.1.<br />

CURRENT ISSUES ON COMORBID CONDITIONS<br />

P. Ruiz<br />

Department of Psychiatry and Behavioral Science, Houston,<br />

TX, USA<br />

Comorbidity conditions have become a major clinical area of interest<br />

in recent years. While we have become very much aware of all the<br />

current diagnostic categories included in the DSM-IV, the presence of<br />

more than one psychiatric illness or condition in day to day psychiatric<br />

practice is the rule rather than the exception. Comorbidity factors<br />

nowadays need to be taken into consideration not only among<br />

psychiatric and medical conditions, but also among psychiatric conditions<br />

as well; for instance, it is common to see major depression or<br />

anxiety disorders manifested together with addictive disorders such<br />

as cocaine dependence. Depressive disorders are among the most<br />

common conditions observed in the field of psychiatry, and, therefore,<br />

it is imperative that we pay attention to the psychiatric conditions<br />

that are concomitantly manifested with depressive disorders in<br />

our daily practice. This paper aims to review the extensive role of<br />

comorbidities related to depression as a major financial burden in the<br />

field of psychiatry, and the evidence about how to appropriately diagnose<br />

and treat these comorbidities.<br />

RS19.2.<br />

CURRENT TREATMENT OF POSTPARTUM<br />

DEPRESSION<br />

N.L. Stotland<br />

Rush Medical College, Chicago, IL, USA<br />

Postpartum depression is finally receiving appropriate public and<br />

professional interest. A book by an American movie star, and her<br />

public statements, have helped to decrease stigma. Psychotherapies<br />

are as effective for postpartum depression as for depression at other<br />

times in life, and can be first-line treatment for mild to moderate cases<br />

of postpartum depression. Patients who are more severely depressed<br />

will probably require pharmacologic treatment. There is some concern<br />

about the possible dangers of some or all psychotropic medications,<br />

particularly the selective serotonin uptake inhibitors (SSRIs)<br />

most commonly used to treat depression, to the breastfeeding infant.<br />

There is an increasing body of knowledge about the appearance of the<br />

various SSRIs in breast milk. However, it may be unwise to change<br />

medication in cases where several agents had to be tried before therapeutic<br />

benefit was achieved. If a woman has taken an SSRI during<br />

pregnancy, and up to the time of delivery, the small amount in breast<br />

milk may even diminish the risk of withdrawal symptoms in the baby.<br />

It is crucial to understand and to explain to the patient the documented<br />

and persistent ill effects that having a mother who is<br />

depressed has on a baby, so that the best possible risk/benefit ratio<br />

can be determined. It is often useful to involve those closest to the<br />

patient in the treatment decision. Since postpartum depression<br />

undermines a new mother’s confidence in her mothering ability, it is<br />

also crucial to encourage and support her in that function.<br />

RS19.3.<br />

CURRENT EDUCATIONAL ISSUES PERTAINING<br />

TO CERTIFICATION IN PSYCHOSOMATIC MEDICINE<br />

D.K. Winstead<br />

Department of Psychiatry and Neurology, Tulane University<br />

School of Medicine, New Orleans, LA, USA<br />

Psychosomatic medicine (formerly known as consultation-liaison psychiatry)<br />

has advanced rapidly in the United States in the past two<br />

decades. Similar advances are also taking place in other industrialized<br />

nations such as Canada, Japan, European countries and others. In<br />

2003, the American Board of Psychiatry and Neurology officially recognized<br />

this field and set about to create a written examination for certification<br />

purposes and a second examination to be taken 10 years later<br />

for maintenance of certification (recertification). At the same time, the<br />

Accreditation Council of Graduate Medical Education approved a one<br />

year fellowship and set forth requirements for official accreditation. To<br />

date approximately 36 programs have been accredited and 853 individuals<br />

have been certified. Criteria for program accreditation are<br />

reviewed, as well as the major topics covered in the content outline of<br />

material that is ultimately tested by the written Board examination. The<br />

examination is administered by computer at a specialized testing center.<br />

Two hundred questions are administered over a 4 hour period.<br />

Although viewed as a subspecialty that would train psychiatrists for an<br />

academic or tertiary care practice, the numbers are not yet robust<br />

enough to sustain the field. Possible remedies for this dilemma would<br />

involve both increased funding for fellowship training as well as<br />

increased reimbursement for patient care services delivered.<br />

RS19.4.<br />

ILLNESS, SPIRITUAL BELIEFS AND CULTURE<br />

IN PSYCHIATRIC CONSULTATIONS<br />

E.F. Foulks<br />

Jefferson Parish Human Services Authority, Metaire, LA, USA<br />

Gallup opinion surveys in the US have found that the number of people<br />

who indicate that they believe in God has remained consistently<br />

around 95%. About a third of these view religious commitment as “the<br />

most” significant component of their lives. Two thirds say religion is<br />

“important or very important” in their lives and indicate a preference<br />

for “a professional counselor who is religious”. Scott Peck has pointed<br />

out that, while patients often invoke religious beliefs to explain their<br />

symptoms of mental disorder, they are seldom elicited by or communicated<br />

to the mental health professional, often resulting in misdiagnosis<br />

and mistreatment. Treating the “whole person”, body and soul, has<br />

been the aim of physicians since antiquity. During the past century,<br />

advances in biomedical science and technology have often shifted<br />

focus of the clinician on biological tests and treatments, sometimes<br />

neglecting the inner-psychological experiences of suffering of the<br />

patient. Returning the clinical gaze once again on the bio-psychosocial-spiritual<br />

needs of the patient seems to be an inevitable emerging<br />

process, one that promises to enrich the experience of healing for the<br />

patient and clinician as well, offering both hope and meaning.<br />

49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!